key: cord-0010220-dvo7bmu4
authors: Britton, P.; Cármenes, R. S.; Page, K. W.; Garwes, D. J.
title: The integral membrane protein from a virulent isolate of transmissible gastroenteritis virus: molecular characterization, sequence and expression in Escherichia coli
date: 2006-10-27
journal: Mol Microbiol
DOI: 10.1111/j.1365-2958.1988.tb00056.x
sha: 7fa4a3aebc0e3e46a032d26a756cee59166ab0d7
doc_id: 10220
cord_uid: dvo7bmu4

Subgenomic mRNA from a virulent isolate of porcine transmissible gastroenteritis virus (TGEV) was used to produce cDNA clones. Part of a new clone and a previously reported clone were sequenced and used to construct the viral gene for integral membrane protein. A single open reading frame (ORF) encoding a polypeptide of 262 amino acids, relative molecular mass (M(r)) 29459, was identified. The positive identification of the polypeptide as the integral membrane protein was demonstrated by the production in E. coli of a chimaeric protein comprising most of the ORF encoding the M(r) 29459 polypeptide and β‐galactosidase. The chimaeric protein reacted with a specific monoclonal antibody to viral integral membrane protein and antibodies raised against the chimaeric protein immune precipitated the viral protein. Comparison with the sequence of an avirulent isolate indicates amino acid residues that may be important in pathogenicity.

TGEV is a coronavirus that causes gastroenteritis in pigs, resulting in a high mortality in neonates. TGEV belongs to the family Coronaviridae, a large group of pleomorphic enveloped viruses with a positive-stranded RNA genome. The coronavirus proteins are expressed from a 'nested' set of subgenomic mRNAs which have common 3' termini but different 5' extensions. The region of each mRNA responsible for the expression of a protein appears to correspond to the 5'-terminal region that is absent on the preceding smaller species. Mouse hepatitis virus (MHV) and infectious bronchitis virus (IBV) mRNA species con-tain identical short non-coding sequences at their 5' ends which appear to be joined to the sequences encoding the viral genes by discontinuous transcription. A consensus sequence identified upstream of each gene/ORF may act as a binding site for the RNA polymerase-leader complex (Spaan et al.. 1983; Brown et al., 1984; Lai et aL, 1984; Budzilowicz et at., 1985; Shieh et at., 1987) . It has been postulated that a heptameric sequence, ACTAAAC (Britton ef a/., 1988), or a hexameric sequence, CTAAAC (Kapke and Brian, 1986; Rasschaert efa/., 1987a; 19B7b) , may be involved in the binding of the TGEV RNA polymerase-leader complex for the transcription of the mRNA species from the negative form of the RNA genome.

The TGEV virion contains three major structural polypeptides: a surface glycoprotein (spike or peplomer protein) with a monomeric M, of 200000, a glycosylated integral membrane protein observed as a series of polypeptides of M, 28000-31000 and a basic phosphorylated protein (the nucleoprotein) of Mr 47000 associated with the viral genomic RNA (Garwes and Pocock, 1975) . TGEV-infected cells have, in addition to the genomic RNA, six species of subgenomic mRNA (Britton et ai., 1986) . Expression and sequencing studies have shown that the two smaller species (1.7 kb and 0.7 kb) contain the nucleoprotein gene and a gene encoding a polypeptide of M, 9000 (Britton eta!., 1986; Kapke and Brian. 1986; Rasschaeri et al., 1987b; Britton et al., 1988) . The mRNA species of 2.6 kb and the largest mRNA species (8-11.2 kb) appear to encode the integral membrane protein and the peplomer protein (Britton etal.. 1986; Jacobs et aL, 1986; Kapke ef a/., 1987; Laude et aL, 1987; Rasschaeriand Laude, 1987; Rasschaeri etat.. 1987a; 1987b) . The other mRNA species of 3kb and 3.9kb (Britton ef al.. 1986; Jacobs et al., 1986) have had no product assigned to them from either infected cells or virions. Jacobs ef aL (1986) identified a product of M^ 24000 from in vitro translation of the 3.9 kb mRNA species (Purdue strain) in rabbit reticulocyte lysate.

The integral membrane proteins from other coronaviruses, including IBV (Boursnell ef ai., 1984) , MHV (Armstrong ef aL, 1984; Pfleiderer et aL, 1986) , bovine coronavirus ((BCV) Lapps et aL, 1987) and the avirulent Purdue strain of TGEV (Kapke ef a/., 1987; Laude ef aL, 1987) have been sequenced. The A/-terminal region of the proteins from MHV and BCV contain 0-linked glycans in which the sugar moieties are joined to serine and threonine residues (Niemann and Klenk. 1981; Niemann etal.. 1984; Lapps e( a/., 1987) , The integral membrane proteins from TGEV {Garwes ef a/., 1984; Jacobs et ai., 1986) and IBV (Stern and Sefton, 1982a) have been shown to have N-linked glycans. The integral membrane proteins from MHV, IBV and BCV do not appear to have an N-terminal cleaved signal sequence (Rottier et al.. 1986; Stern and Sefton, 1982b; Lapps etai., 1987) . However, Laude etal. (1987) demonstrated that the integral membrane protein from the Purdue strain of TGEV contained a cleaved 17-amino-acid signal sequence. A model for the membrane topology of the integral membrane protein for coronaviruses has been postulated from a combination of biochemical and primary sequence data from WHV (Armstrong etai., 1984; Rottier etal., 1986) .

Here we describe the cloning and sequence of the integral membrane protein gene of a virulent field isolate of TGEV, provide experimental confirmation that the gene encodes the integral membrane protein and compare its primary structure with that of three other coronaviruses.

Cloning from TGEV mRNA species TGEV poly(A)-containing mRNA species were isolated from virus-infected LLC-PK1 cells and used for the synthesis of cDNA. The production of plasmid pF4F-36 was described by Britton et ai. (1988) . Plasmid pTG22 was produced using a synthetic oligonucleotide as primer for cDNA synthesis. Plasmid pF4F-36 was found to hybridize, by Northern blot analysis, tp all the TGEV mRNA species except the 0.7 kb species, postulated to express a polypeptide of M, 9000 found at the 3' end of the viral genome (Britton et al., 1988) . Plasmid pTG22 did not hybridize to either the 0.7 kb or 1.7 kb mRNA species, indicating that it originated within the 2.6 kb mRNA species previously shown, by in vitro translation in rabbit reticulocyte lysates, to express the TGEV integral membrane protein (Britton et ai., 1986; Jacobs etai., 1986) . From the size and position of the cDNA insert on the TGEV genome, pF4F-36 was deduced to contain about 80% of the integral membrane protein. Plasmid pTG22 is 2.5 kbp long and from its restriction map was shown to overlap pF4F-36 ( Fig. 1) and extend 4.6 kb into the TGEV genome, thus completing the cloning of the integral membrane protein gene.

A 0.44 kbp Nsi\ fragment from pTG22, containing restriction sites at one end that overlapped with pF4F-36, was purified and ligated to a 0.5 kbp Nsi\-Bal\ fragment from pF4F-36 to produce a 0,94 kbp contiguous piece of TGEV cDNA (Fig. 2) . The 0.94 kbp fragment was digested using Hg/Al to produce a 0.83 kbp fragment containing the complete integral membrane protein gene. The HgiA\ site. 22 bp upstream of the integral membrane protein gene initiation site, deduced from sequence data, was endrepaired using the Klenow fragment of E coii DNA polymerase I, and BamH\ linkers were added. The resulting BamHI cassette was cloned into pBR322 as described by Britton et ai. (1988) 

Restriction fragments obtained from plasmids pF4F-36 and pBIM3 were subcloned into M13mp vectors and sequenced in both directions. The cDNA was translated in all six reading frames and translation in the virus sense strand revealed an ORF of 786 bp. The corresponding DNA sequence, 21 bp from the 5' end of the ORF to the start of the TGEV nucleoprotein gene, present in pF4F-36 {Britton etal., 1988), is illustrated in Fig. 3 . Two other ORFs were found in the viral sense strand: one was composed of 20 ammo acids positioned between nucleotides 57-116, and the other comprised 43 amino acids between nucleotides 141 -269, within the integral membrane protein gene. Three ORFs were identified, in the complementary strand; one of 45 amino acids (nucleotides 78-212), one of 62 amino acids {nucleotides 246-431), and another of 33 amino acids {nucleotides 519-617), within the integral membrane protein gene. None of the internal ORFs were preceded by the potential RNA polymerase-leader complex binding site.

The 786 bp ORF, initiating from the ATG at position 22, overlapped both cDNA inserts and encoded a polypeptide of 262 amino acids with a M, 29459. The 5' end of this ORF mapped at 2.5kb from the 3' end of the viral genome and, from its length and position, corresponded to the unique region present in the 2.7 kb mRNA species. The difference between molecular weights of the deduced polypeptide and those found in infected cells and virions is due to post-translational processing. The integral membrane protein is often found as a series of polypeptides when analysed by SDS-polyacrylamide gel electrophoresis.

The nucleotide sequence ( Fig. 3 ) revealed the presence, near the 5' end of the 786bp ORF, of the heptameric sequence, ACTAAAC, also found 5' of the ATG sequences at the start of the TGEV nucleoprotein gene and the ORF encoding the polypeptide of M, 9000 (Britton et al., 1988) . The sequence context, CAAAATGA, about the first ATG of the 786 bp ORF, downstream of the ACTAAAC sequence, is favourable for initiation by eukaryotic ribosomes ((CC) ACCATGG; Kozak, 1983; , A second ATG, found 60bp from the first ATG, lies in a less favourable context.

The M, 29459 polypeptide, encoded by the 786 bp ORF, contains about 46% hydrophobic amino acid residues spread over five domains. The sequence is about 96% identical to that described by Kapke ef al. (1987) and Laude ef al. (1987) , who sequenced the integral membrane protein gene from the avirulent Purdue strain of TGEV and postulated that the protein was the TGEV integral membrane protein because of its homology to the integral membrane protein genes sequenced from IBV and MHV (Armstrong et al., 1984) . AATGCAATTCTITGCGTrAGTGCATTAGGAAGAAGCTA'rG'nXTTCCTCTTGAAGGTGTG 540

ACTATTTICTACACACTTGTTGGCAAG^UtfJTTGAAAGaU^GTACnGCGACTGGATGGGCT 720 TIVYTLVGKKLKASSATGWA TACTATGTAAAATCTAAAGCTGGTGATTACTCAACAGATGCAAGAACTGATAATTTCfiGT 7B0

The nucleotide sequence ol lhe TGEV integral membrane protein gene. The amino acid sequences are the integral membrane protein (nucleotides 22-807) and the start of the nucleoprotein gene (nucleotides 823-840), The ACTAAAC consensus sequence preceding each gene is underlined, Amino acids below the major sequence are substitutions found in the Purdue strain (unbracketed by Kapke ef a/.. 1987 and bracketed by Laude et al.. 1987) . The boxed amino acids are identical residues found between IBV (Boursnell e( al., 1984) , MHV (Armstrong efa/.. 1984) and BCV (Lapps efa,'.. 1987) . T^e small arrow at the N-termJnus of the protein is the signal peptidase cleavage site, as identitied by Laude et al. (1987) . The black dots above asparagine residues indicate potential W-glycosylation sites. The broken lines refer to areas of homology between the four integral membrane proteins derived by dot-matrix analysis (Fig. 5) , The thick black line represents the postulated membrane-spanning regions. These sequence data have been submitted to the EMBL/GenBank Data Libraries under the accession number Y00560. Laude ef al. (1987) identified a 17-amino-acid sequence at the A/-terminal end of the protein as a putative signal sequence that is lost upon incorporation of the TGEV integral membrane protein into cell membranes. The same 17-amino-acid sequence, except for a conservative substitution of an isoleucine for a leucine residue at amino acid residue 3 resulting from a change in the first base of the codon, Is encoded from our cDNA sequence. Cleavage of the leader sequence results in a polypeptide of 245 amino acids vi/ith a predicted M^ of 27 712, of which 44% of the residues are hydrophobic; this polypeptide has an overall charge of +5 at neutral pH (identical to the Purdue strain but distributed over different amino acids). The size of the cleaved product is in agreement with a polypeptide of Mr 26000 found by Garwes ef al. (1984) for the expression of TGEV mRNA species in rabbit reticulocyte lysates or in TGEV-infected cells in the presence of tunicamycin; and with a potypeptide of M^ 25 000 identified by Jabobs et al. (1986) using the same analyses.

In order to prove that the polypeptide of M, 29459 encoded by the 786 bp ORF was the viral integral membrane protein, H/ndlll linkers were added to a 0.88kbp Fsp\ fragment from plasmid pBIM3 containing 95% of the complete gene. This was then ligated into the H/ndlll site of the lacZ gene in plasmid pUR290. The 0.88kbp Fspl fragment consisted of the TGEV integral membrane protein gene 39 bp downstream from the start of the gene to the Fspl site 113bp from the BamHI site in pBR322. This resulted in removal of DNA encoding most of the amino acids from the signal sequence at the N-terminal end of the protein. The recombinant plasmid pURIM-2 expressed a chimaeric protein of M, 140000, upon induction with IPTG, which consisted of part of the TGEV integral membrane protein fused to the C-terminal end of p-galactosidase. A specific monoclonal antibody to the integral membrane protein from the Purdue strain of TGEV, 3BB3, reacted with the chimaeric protein by immunoblot analysis (Fig. 4A) . The chimaeric protein was purified from SDSpolyacrylamide gels and used to raise antibodies in mice. The antibodies immune-precipitated the TGEV integral membrane protein, further confirming that the cDNA encoded the viral integral membrane protein gene (Fig.  4B ).

The complete integral membrane protein gene (from a British field isolate of TGEV) was cloned over two cDNA fragments and then sequenced. A major ORF of 786bp was identified in the viral-sense strand. The initiation codon of the ORF was preceded by the heptameric sequence, ACTAAAC, vi^hich was previously described as preceding both the TGEV nucleoprotein gene and an ORF encoding a poiypeptide of Mr 9068 at the 3' end of the virai genome. The 786 bp ORF encoded a primary transiation product of 262 amino acids vi/ith a M, 29 459. The first 17 amino acids fulfil the criteria of being a eukaryotic signal sequence, having a net charge following the W-terminus and a hydrophobic uncharged region of 14 amino acids (McGeoch, 1985; Von Heijne, 1986) . The cleavage site, identified by Laude et al. (1987) for the Purdue strain of TGEV, is located betvi^een a glutamic acid and an arginine residue. The signal sequence is predicted to fall between the glycine (16) and glutamic acid (17) residues (score = 10.2) by the weight-matrix rule of Von Heijne (1986), which predicts 75 to 80% of eukaryotic signal sequences. The ORF encoding the polypeptide of Mr 29459 was confirmed as the TGEV integral membrane protein gene by constructing a fusion between most of the 786 bp ORF and the E coli lacZ gene In a similar way to that described for the TGEV nucleoprotein gene (Britton et at., 1987) . The gene fusion resulted in the synthesis, in E coli cells, of a polypeptide of M, 140000 composed of p-galactosidase with most of the TGEV integral membrane protein gene attached to the C-terminal end. A monoclonal antibody, 3BB3, specific for TGEV integral membrane protein interacted with the chimaeric polypeptide, and antibodies raised against the chimaera precipitated the integral membrane protein from TGEV-infected cells. This confirmed that the 786 bp ORF, predicted to direct the synthesis of a polypeptide of Mr 29459, was the viral integral membrane protein gene.

Comparison of the M, 29459 product, using a dotmatrix analysis program (DIAGON; Staden, 1982) , with the integral membrane proteins from MHV, IBV and BCV in a pairwise manner revealed remarkable homology between the proteins (Fig. 5 ). There are four major areas of homology between the integral membrane proteins of TGEV (FS772/70), MHV (A59) and BOV (Mebus), whereas there are oniy two regions of homology between TGEV and IBV (Beaudette) as also seen between IBV and either MHV or BCV (Fig. 5) . The homology between MHV and BCV is almost 100%, indicating that the two viruses probably share recent common ancestral evolution. From the homoiogies between the integral membrane proteins, this paper, and the nucleoproteins, Britton et al. (1988) , it is clear that TGEV and MHV share a more recent ancestral evolution than either virus with IBV and it will be interesting to compare homologies with other coronaviruses once their gene sequences have been completed. Direct alignment of the integral membrane proteins from TGEV strains FS772/70 (virulent) and Purdue (avirulent) with MHV (A59), BCV (Mebus) and IBV (Beaudette) using the GAP program {Devereux et ai, 1984) identified the position of identical amino acids between different viruses or in some cases between all fourviruses (Fig. 6) , which are indicated on the deduced amino acid sequence of TGEV integral membrane protein (Fig. 3) . The optimal alignment identified a perfectly conserved eight-amino-acid sequence, SWWSFNPE, between all four viruses (Figs 3 and 6) . The alignment of the amino acid sequences alloweci the identification of the three membrane-spanning regions for TGEV by deduction from the regions identified for MHV (Rottier et ai, 1986) . These are shown as thick black lines on Figs 3 and 6. The regions consist of very similar amino acids between TGEV and MHV, indicating that the regions are weli conserved between viruses, with very few changes between strains of the same virus. Anaiysis of the hydropathicity (Kyte and Dooiittie, 1982) of the TGEV integral membrane protein identified five hydrophobic regions. The first region, covering amino acids 1-17. is the putative signal sequence. The next three regions, covering amino acids 54-74, 80-100 and 114-134, are the three postulated membrane-spanning regions identified from Fig. 6 . The fifth hydrophobic region, covering amino acids 150-220, is the one postulated to interact with the inside of the viral envelope. The remaining 42 residues at the C-terminus have an overall hydrophilic nature similar to the region seen in MHV, and may interact with the nucleoprotein. Thus It is possible to predict the membrane topology of the TGEV integral membrane protein from the DNA sequence data when compared to those of other coronaviruses.

The coronavirus integral membrane protein is glycosylated and has been reported to be of the W-linked type for TGEV (Garwes et al., 1984; Jacobs et ai, 1986) and IBV (Stern and Sefton, 1982a) , whereas MHV and BCV are of the O-linked type Lapps e( al.. 1987) . There are three potential W-glycosylation sites within the integral membrane protein: at asparagine positions 32, 55 and 251, as deduced from the DNA sequence for TGEV. The first two are at the amino terminal of the polypeptide (Fig. 3) although the second site (Asn-55) falls within the first predicted membrane-spanning region (Figs  3 and 6) , as determined from alignment with MHV, and so It may not be glycosylated. The third potential glycosylation site is at the carboxy-terminal end of the polypeptide, predicted to be found inside the virion, and so it may not be glycosylated. The prediction that only the first A/-glycosylation site is functional would give rise to a polypeptide of Mf 29000-30000, a size close to the major species identified by SDS polyacrylamide gel electrophoresis of either TGEV-infected cells or purified virions, since the presence of an W-Nnked glycan may add up to 2000 to the molecular weight of a poiypeptide (Klenk and Rott, 1980) . Other species of the integral membrane protein observed on SDS gels from both TGEV-infected cells and virions may arise from heterogeneity in the oligosaccharide side chains and from incomplete glycosylation.

The homology between the two strains of TGEV in the amino acid and nucleotide sequences is 98%. There are 11 amino acid substitutions between strain FS772/70 and the avirulent Purdue strain, as determined by Kapke etai. (1987) , and 12 substitutions from the Purdue strain, as determined by Laude ef ai. (1987) ; see Figs 3 and 6. A comparison of the sequences of avirulent viruses is important in identifying regions that may be involved in pathogenicity. Any conformational change in the amino acid backbone may affect receptor binding affinities and give rise to different epitope sites. The data on the virulent strain studied here provide a framework for the identification of the amino acids which play a key role in these processes.

Preparation of viral RNA TGEV mRNA was prepared from LLC-PKl cells infected with TGEV strain FS772-70 and purified from other RNA species on poly(U) Sepharose, as described previously (Britton etal.. 1987; 1988) .

Standard recombinant DNA methods were used (Maniatis ef al.. 1982) with enzymes purchased from New England Biolabs (CP Laboratories, Bishop's Stortford, UK) unless otherwise stated in the text. DNA fragments were isolated from agarose gels by freeze-phenol elution (Silhavy et ai.. 1984) . Ligation reactions were carried out as described by Britton et ai. (1984) . E. coii cells were routinely transformed using the RbCI method developed by V. Simanis (Hanahan, 1985) . E. coli strain DH1 was used for routine plasmid construction and JM101 for expression of the chimaeric protein, E. coii transformants were selected on LB plates containing ampiciilin (100 |ig rnl"'). Vector DNA was routinely treated with alkaline phosphatase prior to ligation.

cDNA synthesis was carried out as described by Britton ef al. (1988) except that a synthetic oligonucleotide, 5'-GCCAnTA-GAAGTTTAGT-3', was used to prime first-strand synthesis and 1200U of Motoney murine leukaemia virus (M-MLV) reverse transcriptase (BRL) was used for the production of cDNA. The primer corresponded to a complementary sequence 13bp upstream from the 5' end of the nucleoprotein gene, derived from the sequence data reported by Britton et al. (1988) , and was synthesized by the phosphoramldite method using an Applied Biosystems model 381A DNA synthesizer. Second-strand synthesis was carried out as described by Britton ef al. (1988) . Following second-Strand synthesis, oligo-dC tails were added to the cDNA molecules using 25 U terminal transferase at 1 S^C for 2 min. The dC-tailed cDNA molecules were annealed to oligo(dG)tailed pUC9 (Pharmacia) at 65°C for 10 min. After 4 h at 58''C. they were transformed into competent DH1 E. coli cells. Transformants containing TGEV cDNA were Identified by colony hybridization, as described by Britton et al. (1988) using a P^P]-labelled TGEV cDNA fragment that hydridized to all of the TGEV mRNA species larger than the 2.7 kb mRNA species.

Various restriction endonuclease fragments from plasmids pF4F-36 and pBIM3 deduced from restriction maps were cloned into M13mp vectors. DNA sequencing and sequence analysis were carried out as described by Britton etal. (1988) ,

ATGEV cDNA fragment containing 95% of the integral membrane protein gene, was ligated into the expression vector pUR290 (Ruther and Muller-Hill, 1983 ) and the resulting plasmid. pURIM-2. was transformed into JM101. Cells containing plasmid pURIM-2 were induced by isopropyl-p-D-thiogalactopyranoside (IPTG) to express the chimaeric protein identified by SDS gel electrophoresis as described by Britton etai (1987) .

Cultures of JM101 (pURIM-2) were grown at 37°C in Luria broth to an absorbance of 0.5 at 680nm, the chimaeric protein was induced by the addition of IPTG (1 mM), and the cells were grown for a further 3h. The cells were collected by centrifugation and lysed by the addition of Laemmli sample buffer and incubation at lOCC. The cell lysate was electrophoresed into 6% preparative polyacrylamide gels. The protein bands were visualised by soaking the gels in 4 M sodium acetate, and the band corresponding to the chimaeric protein was excised from the gel, crushed and electroetuted from the acrylamide as described by Britton {1981). The purified chimaeric protein was used to immunize Balb/C mice, as described by Garwes etai (1987) .

Immunoblot analysis was carried out as described by Britton etai (1988) except that monoclonal antibody, 3BB3 (Jimenez et ai, 1986) . raised against TGEV integral membrane protein was used as a probe. Immune precipitation was carried out as described by Britton etai (1987) except that the formalin-fixed Staphylococcus aureus cells used were obtained from BRL (Immunoprecipitin. 560-9321SA).

Sequence and topology of a model intraceliular membrane protein. El glycoprotein, from a coronavirus

Sequence of the membrane protein gene from avian coronavirus IBV

Phosphotransferase-mediated regulation of carbohydrate utilisation in Escherichia co// KI 2: identification of the products of genes on the specialised transducing phages kiex(crr) and kgsr(tgs)

Location and direction of transcription of the ptsH and ptsi genes on the Escherichia coli K12 genome

Towards a geneticallyengineered vaccine against porcine transmissible gastroenteritis virus

Expression of porcine transmissible gastroenteritis virus genes in E. coli as p-galactosidase chimaeric proteins

{1988) Sequence of the nucleoprotein from a virulent British field isolate of transmissible gastroenteritis virus and its expression in Saccharomyces cerevisiae

Aleader sequence is present on mRNA A of avian infectious bronchitis virus

{1985) Three intergenic regions of coronavirus mouse hepatitis virus strain A59 genome RNA contain a common nucleotide sequence that is homologous to the 3' end of the viral mRNA leader sequenoe

{1981) Coronavirus cell-associated RNA-dependent RNA polymerase

and Smithies. O. {1984) A comprehensive set of sequence analysis programs for the VAX

The polypeptide structure of transmissible gastroenteritis virus

{1975) Identification of heat-dissociable RNA complexes in two porcine coronavinjses

Defective replication of porcine transmissible gastroenteritis virus in a continuous cell line

{1987) Identification of epitopes of immunological importance on the peplomer of porcine transmissible gastroenteritis virus

Techniques for transformation of Escherichia coti

Characterization and translation of transmissible gastroenteritis virus mRNAs

Critical epitopes in transmissible gastroenteritis virus neutralization

Sequence analysis of the porcine transmissible gastroenteritis coronavirus nucleocapsid protein gene

Nucleotide sequence of the porcine transmissible gastroenteritis coronavirus matrix protein

Cotranslational and posttranslational processing of viral glycoproteins

Comparison of initiation of protein synthesis in prokaryotes, eukaryotes and organelles

Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes

A simple method for displaying the hydropathic character of a protein

Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus

Sequence analysis of the bovine coronavirus nucleocapsid and matrix protein genes

Sequence and W-terminal processing of the transmembrane protein El of the coronavirus transmissible gastroenteritis virus

Molecular Cloning: A Laboratory Manual

On the predictive recognition of signal peptide sequences

Coronavirus glycoprotein El, a new type of viral glycoprotein

The carbohydrates of mouse hepatitis virus (MHV) A59: structures of the 0-glycosidically linked oligosaccharides of glycoprotein E1

Coronavirus MHV-JHM: nucleotide sequence of the mRNA that encodes the membrane protein

The predicted structure of the peplomer protein E2 of the porcine coronavirus transmissible gastroenteritis virus

Surface glycoproteins of transmissible gastroenteritis virus: functions and gene sequence

Enteric coronavirus TGEV: partial sequence of the genomic RNA, its organisation and expression

Predicted membrane topology of the coronavirus protein El

Easy identification of cDNA clones

The 5'-end sequence of the murine coronavirus genome: implications for multiple fusion sites in leader-primed transcription

Experiments With Gene Fusions

Coronavirus mRNA synthesis involves fusion of non-contiguous sequences

An interactive graphics program for comparing and aligning nucleic acid and amino acid sequences

Coronavirus proteins: stmcture and function of the oligosaccharides of the avian infectious bronchitis virus glycoproteins

Coronavirus proteins: biogenesis of avian infectious bronchitis virus virion proteins

A new method for predicting signal sequence cleavage sites

This research was supported by the Biomolecular Engineering Programme of the Commission of the European Communities (Contract No. GB1 -2-089-UK). R. S. Carmenes (from the Departamento de Bioquimica, Universidad de Oviedo, Spain) was supported by a Fleming Award from the Spanish Ministerio de Educaoion y Ciencia and the British Council. We would like to thank Dr J. McCauiey from the Pirbright Laboratory of this Institute for synthesii:ing the oligonucleotide primer, and Dr L. Enjuanes from the Centro de Biologia Molecular, Madrid for providing the monoclonal antibody (3BB3) against the integral membrane protein of the Purdue strain of TGEV.